RC
Recordati Industria Chimica e Farmaceutica S.p.A.
RCDTF · OTC
$58.00 +0.00% (+$0.00)
Market Cap 10.3B €
P/E Ratio 20.80x
Div. Yield 2.68%
ROE 24.75%
Bulios Fair Price
$52.46
9.6% downside
Current Price
$58
Undervalued Fair Value Overvalued
According to Bulios Fair Price, RCDTF is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Strong
7/9Valuation
56 /100
Fair EV/EBITDA 12.37x
P/S 3.82x
P/B 4.86x
Growth
71 /100
Growing Rev. growth 12.21%
FCF growth 11.89%
Book val. growth 7.48%
Profitability
100 /100
Strong Net margin 18.38%
Op. margin 30.47%
FCF margin 21.50%
Quality
78 /100
Excellent ROE 24.75%
ROA 9.28%
Asset turnover 0.51x
Debt
59 /100
Moderate Current ratio 1.26x
Int. coverage 7.71x
Net debt/EBITDA 1.93x
Stability
98 /100
Stable Rev. volatility 0.34%
EPS volatility 10.44%
Profitable years 6
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about RCDTF
Online
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Robert Koremans
Employees
4,693
Headquarters
Milan
Upcoming events
10 NOV
Earnings
Upcoming earnings report